Feasibility and impact of carbon dioxide angiography on acute kidney injury following endovascular interventions in patients with peripheral artery disease and renal impairment.
Carbon dioxide angiography
Chronic kidney disease
Endovascular revascularization
Iodinated contrast medium
Peripheral artery disease
Post-contrast acute kidney injury
Journal
Journal of nephrology
ISSN: 1724-6059
Titre abrégé: J Nephrol
Pays: Italy
ID NLM: 9012268
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
24
06
2020
accepted:
10
11
2020
pubmed:
9
2
2021
medline:
23
7
2021
entrez:
8
2
2021
Statut:
ppublish
Résumé
Post-contrast acute kidney injury (AKI) is a dreaded complication of endovascular revascularization using iodinated contrast medium in patients with peripheral artery disease and concomitant chronic kidney disease (CKD). This study sought to evaluate the incidence of AKI in patients with peripheral artery disease and CKD undergoing endovascular revascularization and using carbon dioxide (CO From 04/2015 to 07/2018, all consecutive peripheral artery disease patients with CKD stage ≥ 3 referred for endovascular revascularization of symptomatic peripheral artery disease were prospectively included. During endovascular revascularization, CO CO
Sections du résumé
BACKGROUND
Post-contrast acute kidney injury (AKI) is a dreaded complication of endovascular revascularization using iodinated contrast medium in patients with peripheral artery disease and concomitant chronic kidney disease (CKD). This study sought to evaluate the incidence of AKI in patients with peripheral artery disease and CKD undergoing endovascular revascularization and using carbon dioxide (CO
METHODS AND RESULTS
From 04/2015 to 07/2018, all consecutive peripheral artery disease patients with CKD stage ≥ 3 referred for endovascular revascularization of symptomatic peripheral artery disease were prospectively included. During endovascular revascularization, CO
CONCLUSION
CO
Identifiants
pubmed: 33555574
doi: 10.1007/s40620-020-00909-8
pii: 10.1007/s40620-020-00909-8
doi:
Substances chimiques
Contrast Media
0
Carbon Dioxide
142M471B3J
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
811-820Références
Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UK, Williams LJ, Mensah GA, Criqui MH (2013) Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382:1329–1340
doi: 10.1016/S0140-6736(13)61249-0
Malyar N, Fürstenberg T, Wellmann J, Meyborg M, Lüders F, Gebauer K, Bunzemeier H, Roeder N, Reinecke H (2013) Recent trends in morbidity and in-hospital outcomes of in-patients with peripheral arterial disease: a nationwide population-based analysis. Eur Heart J 34:2706–2714
doi: 10.1093/eurheartj/eht288
Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I, ESC Scientific Document Group (2018) 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 39:763–816
doi: 10.1093/eurheartj/ehx095
Lawall H, Huppert P, Espinola-Klein C, Rümenapf G (2016) The diagnosis and treatment of peripheral arterial vascular disease. Dtsch Arztebl Int 113:729–736
pubmed: 27866570
pmcid: 5150211
Setacci C, de Donato G, Teraa M, Moll FL, Ricco JB, Becker F, Robert-Ebadi H, Cao P, Eckstein HH, De Rango P, Diehm N, Schmidli J, Dick F, Davies AH, Lepäntalo M, Apelqvist J (2011) Chapter IV: treatment of critical limb ischaemia. Eur J Vasc Endovasc Surg 42(Suppl 2):S43–S59
doi: 10.1016/S1078-5884(11)60014-2
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, TASC II Working Group, Bell K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J, Clement D, Creager M, Jaff M, Mohler E 3rd, Rutherford RB, Sheehan P, Sillesen H, Rosenfield K (2007) Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 33(Suppl 1):S1–75
doi: 10.1016/j.ejvs.2006.09.024
McCullough PA, Choi JP, Feghali GA, Schussler JM, Stoler RM, Vallabahn RC, Mehta A (2016) Contrast-induced acute kidney injury. J Am Coll Cardiol 68:1465–1473
doi: 10.1016/j.jacc.2016.05.099
Lüders F, Bunzemeier H, Engelbertz C, Malyar NM, Meyborg M, Roeder N, Berger K, Reinecke H (2016) CKD and acute and long-term outcome of patients with peripheral artery disease and critical limb ischemia. Clin J Am Soc Nephrol 11:216–222
doi: 10.2215/CJN.05600515
Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, Farid N, McManamon PJ (1989) Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 320:143–149
doi: 10.1056/NEJM198901193200303
van der Molen AJ, Reimer P, Dekkers IA, Bongartz G, Bellin MF, Bertolotto M, Clement O, Heinz-Peer G, Stacul F, Webb JAW, Thomsen HS (2018) Post-contrast acute kidney injury—part 1: definition, clinical features, incidence, role of contrast medium and risk factors: Recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol 28:2845–2855
doi: 10.1007/s00330-017-5246-5
Gurm HS, Dixon SR, Smith DE, Share D, Lalonde T, Greenbaum A, Moscucci M, BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) Registry (2011) Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 58:907–914
doi: 10.1016/j.jacc.2011.05.023
Prasad A, Ortiz-Lopez C, Khan A, Levin D, Kaye DM (2016) Acute kidney injury following peripheral angiography and endovascular therapy: a systematic review of the literature. Catheter Cardiovasc Interv 88:264–273
doi: 10.1002/ccd.26466
Prasad A, Hughston H, Michalek J, Trevino A, Gupta K, Martinez JP, Hoang DT, Wu PB, Banerjee S, Masoomi R (2019) Acute kidney injury in patients undergoing endovascular therapy for critical limb ischemia. Catheter Cardiovasc Interv 94:636–641
doi: 10.1002/ccd.28415
Waybill MM, Waybill PN (2001) Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 12:3–9
doi: 10.1016/S1051-0443(07)61394-3
Lüders F, Malyar N, Meyborg M, Gebauer K, Brand E, Reinecke H (2012) Impact of peripheral arterial occlusive disease on the development of contrast medium-induced acute kidney injury. Nephron Clin Pract 122:38–43
doi: 10.1159/000346105
Moos JM, Ham SW, Han SM, Lew WK, Hua HT, Hood DB, Rowe VL, Weaver FA (2011) Safety of carbon dioxide digital subtraction angiography. Arch Surg 146:1428–1432
doi: 10.1001/archsurg.2011.195
Khwaja A (2012) KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 120:c179–184
Deutsche Gesellschaft für Angiologie—Gesellschaft für Gefäßmedizin (2016) S3-Leitlinie PAVK—Diagnostik, Therapie und Nachsorge der peripheren arteriellen Verschlusskrankheit. Vasa 45(Suppl 95):1–96
Schulte KL, Amendt K, Hoffmann U, Tiefenbacher C, Weiss T, Mudra H, Hardung D, Nikol S (2012) Curriculum for interventional therapy for arterial diseases. Clinical competence for execution of catheter-based interventions on the arteries of the extremities, on the pelvic, visceral and renal arteries, on the extracranial arteries supplying the brain, and on dialysis shunts. Vasa 41:463–476
doi: 10.1024/0301-1526/a000240
Latus J, Schwenger V, Schlieper G, Reinecke H, Hoyer J, Persson PB, Remppis BA, Mahfoud F (2020) Contrast medium-induced acute kidney injury—consensus paper of the working group “Heart and Kidney” of the German Cardiac Society and the German Society of Nephrology. Kardiologe. https://doi.org/10.1007/s12181-020-00411-2
doi: 10.1007/s12181-020-00411-2
Fujihara M, Kawasaki D, Shintani Y, Fukunaga M, Nakama T, Koshida R, Higashimori A, Yokoi Y (2015) CO
doi: 10.1002/ccd.25722
Ghumman SS, Weinerman J, Khan A, Cheema MS, Garcia M, Levin D, Suri R, Prasad A (2017) Contrast induced-acute kidney injury following peripheral angiography with carbon dioxide versus iodinated contrast media: a meta-analysis and systematic review of current literature. Catheter Cardiovasc Interv 90:437–448
doi: 10.1002/ccd.27051
Morsey H, Aslam M, Standfield N (2003) Patients with critical ischemia of the lower limb are at risk of developing kidney dysfunction. Am J Surg 185:360–363
doi: 10.1016/S0002-9610(02)01406-X
Arora P, Davari-Farid S, Pourafkari L, Gupta A, Dosluoglu HH, Nader ND (2015) The effect of acute kidney injury after revascularization on the development of chronic kidney disease and mortality in patients with chronic limb ischemia. J Vasc Surg 61:720–727
doi: 10.1016/j.jvs.2014.10.020
Goldenberg I, Chonchol M, Guetta V (2009) Reversible acute kidney injury following contrast exposure and the risk of long-term mortality. Am J Nephrol 29:136–144
doi: 10.1159/000151772